1fme

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (18:35, 29 November 2023) (edit) (undo)
 
(10 intermediate revisions not shown.)
Line 1: Line 1:
-
[[Image:1fme.jpg|left|200px]]
 
-
{{Structure
+
==SOLUTION STRUCTURE OF FSD-EY, A NOVEL PEPTIDE ASSUMING A BETA-BETA-ALPHA FOLD==
-
|PDB= 1fme |SIZE=350|CAPTION= <scene name='initialview01'>1fme</scene>
+
<StructureSection load='1fme' size='340' side='right'caption='[[1fme]]' scene=''>
-
|SITE=
+
== Structural highlights ==
-
|LIGAND=
+
<table><tr><td colspan='2'>[[1fme]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1FME OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1FME FirstGlance]. <br>
-
|ACTIVITY=
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr>
-
|GENE=
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1fme FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1fme OCA], [https://pdbe.org/1fme PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1fme RCSB], [https://www.ebi.ac.uk/pdbsum/1fme PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1fme ProSAT]</span></td></tr>
-
|DOMAIN=
+
</table>
-
|RELATEDENTRY=
+
<div style="background-color:#fffaf0;">
-
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1fme FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1fme OCA], [http://www.ebi.ac.uk/pdbsum/1fme PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1fme RCSB]</span>
+
== Publication Abstract from PubMed ==
-
}}
+
-
 
+
-
'''SOLUTION STRUCTURE OF FSD-EY, A NOVEL PEPTIDE ASSUMING A BETA-BETA-ALPHA FOLD'''
+
-
 
+
-
 
+
-
==Overview==
+
The computational redesign of the second zinc finger of Zif268 to produce a 28 residue peptide (FSD-1) that assumes a betabetaalpha fold without metal binding was recently reported. In order to explore the tolerance of this metal-free fold towards sequence variability, six additional peptides resulting from the ORBIT computational protein design process were synthesized and characterized. The experimental stabilities of five of these peptides are strongly correlated with the energies calculated by ORBIT. However, when a peptide with a mutation in the beta-turn is examined, the calculated stability does not accurately predict the experimentally determined stability. The NMR solution structure of a peptide incorporating this mutation (FSD-EY) reveals that the register between the beta-strands is different from the model structure used to select and score the sequences. FSD-EY has a type I' turn instead of the target EbaaagbE turn (rubredoxin knuckle). Two additional peptides that have improved side-chain to backbone hydrogen bonding and turn propensity for the target turn were characterized. Both are of stability comparable to that of FSD-1. These results demonstrate the robustness of the ORBIT protein design methods and underscore the need for continued improvements in negative design.
The computational redesign of the second zinc finger of Zif268 to produce a 28 residue peptide (FSD-1) that assumes a betabetaalpha fold without metal binding was recently reported. In order to explore the tolerance of this metal-free fold towards sequence variability, six additional peptides resulting from the ORBIT computational protein design process were synthesized and characterized. The experimental stabilities of five of these peptides are strongly correlated with the energies calculated by ORBIT. However, when a peptide with a mutation in the beta-turn is examined, the calculated stability does not accurately predict the experimentally determined stability. The NMR solution structure of a peptide incorporating this mutation (FSD-EY) reveals that the register between the beta-strands is different from the model structure used to select and score the sequences. FSD-EY has a type I' turn instead of the target EbaaagbE turn (rubredoxin knuckle). Two additional peptides that have improved side-chain to backbone hydrogen bonding and turn propensity for the target turn were characterized. Both are of stability comparable to that of FSD-1. These results demonstrate the robustness of the ORBIT protein design methods and underscore the need for continued improvements in negative design.
-
==About this Structure==
+
The beta-beta-alpha fold: explorations in sequence space.,Sarisky CA, Mayo SL J Mol Biol. 2001 Apr 13;307(5):1411-8. PMID:11292351<ref>PMID:11292351</ref>
-
1FME is a [[Protein complex]] structure of sequences from [http://en.wikipedia.org/wiki/ ]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1FME OCA].
+
-
 
+
-
==Reference==
+
-
The beta-beta-alpha fold: explorations in sequence space., Sarisky CA, Mayo SL, J Mol Biol. 2001 Apr 13;307(5):1411-8. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/11292351 11292351]
+
-
[[Category: Protein complex]]
+
-
[[Category: Mayo, S L.]]
+
-
[[Category: Sarisky, C A.]]
+
-
[[Category: beta-beta-alpha]]
+
-
[[Category: designed protein]]
+
-
[[Category: fsd-1]]
+
-
[[Category: zinc finger]]
+
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 20:25:47 2008''
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 +
</div>
 +
<div class="pdbe-citations 1fme" style="background-color:#fffaf0;"></div>
 +
== References ==
 +
<references/>
 +
__TOC__
 +
</StructureSection>
 +
[[Category: Large Structures]]
 +
[[Category: Mayo SL]]
 +
[[Category: Sarisky CA]]

Current revision

SOLUTION STRUCTURE OF FSD-EY, A NOVEL PEPTIDE ASSUMING A BETA-BETA-ALPHA FOLD

PDB ID 1fme

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools